OXB to present at the Leerink Partners Global Healthcare Conference
OXB to present at the Leerink Partners Global Healthcare Conference Oxford, UK – 26 February 2025: OXB (LSE: OXB), a global quality and ...
GlobalData on MSN7d
Boehringer and partners commence gene therapy trial for cystic fibrosis
Boehringer Ingelheim, the UK Respiratory Gene Therapy Consortium (GTC), IP Group and Oxford BioMedica (OXB) have commenced ...
thebusinessmagazine10d
Revenues up 44 per cent at OXB as biotech’s pivot pays off
OXB (formerly Oxford Biomedica) expects to report revenues of between £127 million and £129 million for the year ended 31 ...
London South East7d
Oxford Biomedica Share Chat (OXB)
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Investing1y
OXB Share News Today
Assess the latest information about the Oxford BioMedica stock. Our team of expert financial journalists are ready to bring you today's top OXB shares news to keep you ahead of the curve. OXB's ...
manilatimes23d
Appointment of Joint Corporate Broker and Joint Financial Adviser
Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...
Morningstar22d
Oxford BioMedica PLC OXB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...